These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Chemical shift magnetic resonance imaging could predict subclinical cortisol production from an incidentally discovered adrenal mass. Yener S; Secil M; Demir O; Ozgen Saydam B; Yorukoglu K Clin Endocrinol (Oxf); 2018 Jun; 88(6):779-786. PubMed ID: 29498083 [TBL] [Abstract][Full Text] [Related]
46. Adrenocortical hyperplasia associated with ACTH-dependent Cushing's syndrome: comparison of the size of adrenal glands with clinical and endocrinological data. Imaki T; Naruse M; Takano K Endocr J; 2004 Feb; 51(1):89-95. PubMed ID: 15004414 [TBL] [Abstract][Full Text] [Related]
47. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences? Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918 [TBL] [Abstract][Full Text] [Related]
48. Reversible pituitary dysfunction in a patient with Cushing's syndrome discovered as adrenal incidentaloma. Inagaki K; Otsuka F; Miyoshi T; Watanabe N; Suzuki J; Ogura T; Makino H Endocr J; 2004 Apr; 51(2):201-6. PubMed ID: 15118271 [TBL] [Abstract][Full Text] [Related]
49. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study. Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435 [TBL] [Abstract][Full Text] [Related]
50. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age. Podbregar A; Janez A; Goricar K; Jensterle M BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549 [TBL] [Abstract][Full Text] [Related]
52. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643 [TBL] [Abstract][Full Text] [Related]
54. Possible ACTH-independent, cortisol-secreting and DHEA-secreting metastatic hepatocellular carcinoma causing Cushing's syndrome. Sacerdote A; Inoue T; Thomas N; Bahtiyar G BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698199 [TBL] [Abstract][Full Text] [Related]
55. Proposed diagnostic criteria for subclinical Cushing's syndrome associated with adrenal incidentaloma. Akehi Y; Kawate H; Murase K; Nagaishi R; Nomiyama T; Nomura M; Takayanagi R; Yanase T Endocr J; 2013; 60(7):903-12. PubMed ID: 23574729 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361 [TBL] [Abstract][Full Text] [Related]
57. Different patterns of steroid secretion in patients with adrenal incidentaloma. Terzolo M; Osella G; Alì A; Borretta G; Magro GP; Termine A; Paccotti P; Angeli A J Clin Endocrinol Metab; 1996 Feb; 81(2):740-4. PubMed ID: 8636297 [TBL] [Abstract][Full Text] [Related]
58. Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature. Zhang Y; Tan J; Yang Q; Du Z; Yang S; He W; Song Y; Hu J; Yang Y; Li Q; Zhang Y; He Y; Cheng Q; J Med Case Rep; 2020 Feb; 14(1):32. PubMed ID: 32075693 [TBL] [Abstract][Full Text] [Related]
60. Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism. Yener S; Demir L; Demirpence M; Mahmut Baris M; Simsir IY; Ozisik S; Comlekci A; Demir T Endocrine; 2017 May; 56(2):308-316. PubMed ID: 28247312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]